...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Effect of Shuangdan Mingmu capsule, a Chinese herbal formula, on oxidative stress-induced apoptosis of pericytes through PARP/GAPDH pathway
【24h】

Effect of Shuangdan Mingmu capsule, a Chinese herbal formula, on oxidative stress-induced apoptosis of pericytes through PARP/GAPDH pathway

机译:双丹明穆胶囊,中草原,通过PARP / GAPDH途径氧化应激诱导的氧化胁迫诱导凋亡的影响

获取原文
           

摘要

Diabetic retinopathy (DR) has become a worldwide concern because of the rising prevalence rate of diabetes mellitus (DM). Despite much energy has been committed to DR research, it remains a difficulty for diabetic patients all over the world. Since apoptosis of retinal microvascular pericytes (RMPs) is the early characteristic of DR, this study aimed to reveal the mechanism of Shuangdan Mingmu (SDMM) capsule, a Chinese patent medicine, on oxidative stress-induced apoptosis of pericytes implicated with poly (ADP-ribose) polymerase (PARP) / glyceraldehyde 3-phosphate dehydrogenase (GAPDH) pathway. Network pharmacology approach was performed to predict biofunction of components of SDMM capsule dissolved in plasma on DR. Both PARP1 and GAPDH were found involved in the hub network of protein-protein interaction (PPI) of potential targets and were found to take part in many bioprocesses, including responding to the regulation of reactive oxygen species (ROS) metabolic process, apoptotic signaling pathway, and response to oxygen levels through enrichment analysis. Therefore, in vitro research was carried out to validate the prediction. Human RMPs cultured with media containing 0.5?mM hydrogen oxide (H2O2) for 4?h was performed as an oxidative-damage model. Different concentrations of SDMM capsule, PARP1 inhibitor, PARP1 activation, and GAPDH inhibitor were used to intervene the oxidative-damage model with N-Acetyl-L-cysteine (NAC) as a contrast. Flow cytometry was performed to determine the apoptosis rate of cells and the expression of ROS. Cell counting kit 8 (CCK8) was used to determine the activity of pericytes. Moreover, nitric oxide (NO) concentration of cells supernatant and expression of endothelial nitric oxide synthase (eNOS), superoxide dismutase (SOD), B cell lymphoma 2 (BCL2), vascular endothelial growth factor (VEGF), endothelin 1 (ET1), PARP1, and GAPDH were tested through RT-qPCR, western blot (WB), or immunocytochemistry (ICC). Overproduction of ROS, high apoptotic rate, and attenuated activity of pericytes were observed after cells were incubated with media containing 0.5?mM H2O2. Moreover, downregulation of SOD, NO, BCL2, and GAPDH, and upregulation of VEGFA, ET1, and PARP1 were discovered after cells were exposed to 0.5?mM H2O2 in this study, which could be improved by PARP1 inhibitor and SDMM capsule in a dose-dependent way, whereas worsened by PARP1 activation and GAPDH inhibitor. SDMM capsule may attenuate oxidative stress-induced apoptosis of pericytes through downregulating PARP expression and upregulating GAPDH expression.
机译:由于糖尿病患者(DM)的患病率升高,糖尿病视网膜病变(DR)已成为全球担忧。尽管有很多能量已经致力于研究博士,但糖尿病患者仍然是世界各地的困难。由于视网膜微血管细胞(RMPS)的凋亡是博士的早期特征,本研究旨在揭示双丹明梅(SDMM)胶囊,这是一种中国专利药物,氧化应激诱导的氧化症患有聚(ADP-核糖)聚合酶(PARP)/甘油醛3-磷酸脱氢酶(GAPDH)途径。进行网络药理学方法以预测溶解在博士上的等离子体中的SDMM胶囊组分的生物抵抗。发现PARP1和GAPDH都参与了潜在靶标的蛋白质 - 蛋白质相互作用(PPI)的集线网络,并被发现参与许多生物过程,包括应对反应性氧(ROS)代谢过程的调节,凋亡信号通路并通过富集分析反应氧水平。因此,进行了体外研究以验证预测。用含有0.5Ω·mm氧化物(H2O2)的培养基培养的人RMP作为氧化损伤模型进行4〜H.使用不同浓度的SDMM胶囊,PARP1抑制剂,PARP1活化和GAPDH抑制剂,用N-乙酰基-1-半胱氨酸(NAC)介入氧化损伤模型作为对比度。进行流式细胞术以确定细胞的凋亡率和ROS的表达。使用细胞计数试剂盒8(CCK8)来确定周细胞的活性。此外,一氧化氮(NO)细胞浓度上清液和内皮一氧化氮合酶(ENOS)的表达,超氧化物歧化酶(SOD),B细胞淋巴瘤2(BCL2),血管内皮生长因子(VEGF),内皮素1(ET1),通过RT-QPCR,Western印迹(WB)或免疫细胞化学(ICC)测试PARP1和GAPDH。在将细胞与含有0.5μMH2O2的培养基一起温育后,观察到ROS,高凋亡率和衰减活性的过度生产。此外,在本研究中,在细胞暴露于0.5μmH2O2之后发现SOD,NO,BCL2和GAPDH的下调和VEGFA,ET1和PARP1的上调,可以通过PARP1抑制剂和剂量中的SDMM胶囊改善 - 依赖途径,而PARP1激活和GAPDH抑制剂恶化。通过下调PARP表达和上调GAPDH表达,SDMM胶囊可以衰减氧化应激诱导的细胞凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号